Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Maris

Showing results (1-10 of 401) with videos related to

Pageof 41
Sort By:
Current Opinion in Pediatrics|January 22, 2005
The biologic basis for neuroblastoma heterogeneity and risk stratificationJohn M Maris
Pediatric Blood & Cancer|October 6, 2005
How does MYCN amplification make neuroblastomas behave aggressively? Still more questions than answersJohn M Maris
Cancer Cell|December 30, 2008
Unholy matrimony: Aurora A and N-Myc as malignant partners in neuroblastomaJohn M Maris
The New England Journal of Medicine|November 19, 2015
Defining Why Cancer Develops in ChildrenJohn M Maris
The New England Journal of Medicine|June 19, 2010
Recent advances in neuroblastomaJohn M Maris
Cancer Cell|January 18, 2020
When Cold Is Hot: Immune Checkpoint Inhibition Therapy for Rhabdoid TumorsMark Yarmarkovich, John M Maris
Cancer Letters|June 2, 2005
Prospects for therapeutic inhibition of neuroblastoma angiogenesisSuzanne Shusterman, John M Maris
Journal of Pediatric Hematology/Oncology|July 9, 2003
Chemotherapy for neuroblastoma: is it all or none?John M Maris, Robert P Castleberry
Cancer Cell|February 21, 2012
PI3King on MYCN to improve neuroblastoma therapeuticsMichael D Hogarty, John M Maris
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
Identifying rare events in rare diseasesEdward F Attiyeh, John M Maris
Pageof 41

Showing results (1-10 of 401) with videos related to

Sort By:
Pageof 41
Current Opinion in Pediatrics|January 22, 2005
The biologic basis for neuroblastoma heterogeneity and risk stratificationJohn M Maris
Pediatric Blood & Cancer|October 6, 2005
How does MYCN amplification make neuroblastomas behave aggressively? Still more questions than answersJohn M Maris
Cancer Cell|December 30, 2008
Unholy matrimony: Aurora A and N-Myc as malignant partners in neuroblastomaJohn M Maris
The New England Journal of Medicine|November 19, 2015
Defining Why Cancer Develops in ChildrenJohn M Maris
The New England Journal of Medicine|June 19, 2010
Recent advances in neuroblastomaJohn M Maris
Cancer Cell|January 18, 2020
When Cold Is Hot: Immune Checkpoint Inhibition Therapy for Rhabdoid TumorsMark Yarmarkovich, John M Maris
Cancer Letters|June 2, 2005
Prospects for therapeutic inhibition of neuroblastoma angiogenesisSuzanne Shusterman, John M Maris
Journal of Pediatric Hematology/Oncology|July 9, 2003
Chemotherapy for neuroblastoma: is it all or none?John M Maris, Robert P Castleberry
Cancer Cell|February 21, 2012
PI3King on MYCN to improve neuroblastoma therapeuticsMichael D Hogarty, John M Maris
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
Identifying rare events in rare diseasesEdward F Attiyeh, John M Maris
Pageof 41